Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcus Biosciences (RCUS) Tax Provisions (2021 - 2024)

Arcus Biosciences has reported Tax Provisions over the past 4 years, most recently at $1.0 million for Q4 2024.

  • Quarterly results put Tax Provisions at $1.0 million for Q4 2024, changed 0.0% from a year ago — trailing twelve months through Sep 2025 was $1.0 million (changed 0.0% YoY), and the annual figure for FY2024 was $1.0 million, down 83.33%.
  • Tax Provisions for Q4 2024 was $1.0 million at Arcus Biosciences, roughly flat from $1.0 million in the prior quarter.
  • Over the last five years, Tax Provisions for RCUS hit a ceiling of $2.0 million in Q4 2021 and a floor of $1.0 million in Q1 2022.
  • Median Tax Provisions over the past 4 years was $1.0 million (2022), compared with a mean of $1.4 million.
  • Biggest five-year swings in Tax Provisions: skyrocketed 100.0% in 2023 and later changed 0.0% in 2024.
  • Arcus Biosciences' Tax Provisions stood at $2.0 million in 2021, then crashed by 50.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024.
  • The last three reported values for Tax Provisions were $1.0 million (Q4 2024), $1.0 million (Q4 2023), and $2.0 million (Q3 2023) per Business Quant data.